SCN5A and long QT syndrome 3: For patients with LQT2 (HERG/KCNH2 channel defects) and LQT3 (SCN5A sodium channel functional gain), the overall efficacy of beta-blockers showed a decreasing trend, and the differences between drugs did not reach statistical significance.